Lateral Flow Assays Market in terms of revenue was estimated to be worth $20.5 billion in 2022 and is poised to reach $22.6 billion by 2027, growing at a CAGR of 2.0% from 2022 to 2027 according to a new report by MarketsandMarkets™. The increasing demand of lateral flow assays due to increase in prevalence of infectious disease, increasing number of geriatric populations in many countries, and rising use of home-based lateral flow assay devices are the major factors driving the growth of this market. On the other hand, reluctance among doctors and patients to change existing diagnostic procedures and the low accuracy of lateral flow assays are the key restraints.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=167205133
Browse in-depth TOC on “Lateral Flow Assays Market”
366 – Tables
58 – Figures
374 – Pages
In this report, the lateral flow assays market is segmented on the basis of product type, application type, technique type, sample type, end user, and region.
“Lateral Flow Readers segment is expected to witness the fastest growth during the forecast period”
Based on product type, the lateral flow assays market is segmented into kits & reagents and lateral flow readers. During the forecast period, this segment is expected to witness the fastest growth during the forecast period. The factors responsible for the growth of this segment are increasing demand of quantitative analysis of clinical sample.
“Veterinary Diagnostics segment accounted for the second largest share of lateral flow assays market in 2021”
Based on applications, the lateral flow assays market is segmented into clinical testing, veterinary diagnostics, food safety & environmental testing, and drug development & quality testing. The veterinary diagnostics segment accounted for the second largest share of the lateral flow assays market in 2021. The possibility of infectious disease outbreaks (particularly in large livestock animals) is driving the demand for lateral flow tests due to their simplicity and rapidity compared to conventional detection methods.
“Multiplex Detection Assays technique is expected to witness the fastest growth during the forecast period”
Based on technique, the lateral flow assay kits & reagents market is segmented into competitive assays, sandwich assays, and multiplex detection assays. The multiplex detection assays technique is expected to witness the fastest growth during the forecast period. The widening scope, applications, and research on multiplex detection assays are expected to boost the growth of this segment in the forecast period.
The lateral flow assays market is segmented into five regions namely North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Asia-Pacific is the second largest region along with fastest growing region of lateral flow assays market owing to major investments in rapid testing in this region.
Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=167205133
Lateral Flow Assays Market Dynamics:
High prevalence of infectious diseases across the globe
Rapidly increasing geriatric population
Growing usage of home-based lateral flow assay devices
Growing demand for point-of-care testing
Need for rapid diagnostic testing for COVID-19
Inconsistent results of lateral flow assay tests
Evolving applications of lateral flow assays
Rising demand for lateral flow assays in the food & beverage industrya. Omicron – The new variant of concern is an opportunity for the lateral flow assays marketb. Government initiatives for omicronc. Initiatives of Medical diagnostic companies for omicron
Limited reimbursements for lateral flow assay products
Difficulties in procuring quality raw materials for the development of lateral flow assay tests
Key Market Players:
The prominent players in the global lateral flow assays market include Abbott Laboratories (US), Quidel Corporation (US), F. Hoffman-La Roche AG (Switzerland), Danaher Corporation (US), Siemens AG (Germany), BD (US), bioMérieux SA (France), Thermo Fisher Scientific, Inc. (US), PerkinElmer Inc. (US), Hologic Inc. (US), QIAGEN N.V. (Netherlands), and Merck KGaA (Germany).
In October 2022, F. Hoffmann-La Roche Ltd. (Switzerland) a next-generation portfolio of SARS-CoV-2 rapid antigen test 2.01, SARS-CoV-2 Rapid Antigen Test 2.0 Nasal2, and SARS-CoV-2 Rapid Antigen Test 2.0 Nasal3
In June 2021, Abbott Laboratories (US) received the CE approval for PanBio Rapid Antigen Self-test, opening access throughout Europe to fast, reliable COVID-19 testing
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=167205133
Company Name: MarketsandMarkets Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Address:630 Dundee Road Suite 430
State: IL 60062
Country: United States